KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Exchange Rate Effect (2016 - 2025)

Gilead Sciences' Exchange Rate Effect history spans 17 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 109.09% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $92.0 million, up 330.0%, while the annual FY2025 figure was $92.0 million, 330.0% up from the prior year.
  • Exchange Rate Effect reached $5.0 million in Q4 2025 per GILD's latest filing, up from -$5.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $75.0 million in Q4 2022 to a low of -$72.0 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is $550000.0, with a median of -$5.5 million recorded in 2023.
  • The largest YoY upside for Exchange Rate Effect was 933.33% in 2022 against a maximum downside of 340.0% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at -$9.0 million in 2021, then soared by 933.33% to $75.0 million in 2022, then crashed by 50.67% to $37.0 million in 2023, then crashed by 248.65% to -$55.0 million in 2024, then soared by 109.09% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Exchange Rate Effect are $5.0 million (Q4 2025), -$5.0 million (Q3 2025), and $73.0 million (Q2 2025).